According to Precedence Research, the global agricultural biotechnology market was evaluated at USD 115.26 billion in 2023 and is expected to attain around USD 242.17 billion by 2032, growing at a CAGR of 8.6% from 2023 to 2032. Agricultural biotechnology serves as a pivotal growth factor within the farming industry, offering cost-effective and streamlined production methods. Engineered crops designed to withstand particular herbicides simplify and enhance weed control processes, driving efficiency. Similarly, crops engineered for resistance against diseases and pests bolster pest management efforts, reducing reliance on synthetic pesticides.

Market Overview

Agricultural biotechnology fuels rapid growth by leveraging scientific techniques to enhance plants, animals, and microorganisms. By harnessing DNA insights, scientists develop solutions that elevate agricultural productivity. Biotechnology enables precise manipulation of genes, empowering breeders to make targeted enhancements in crops and livestock. This approach unlocks improvements beyond what traditional breeding methods alone can achieve.

Get report sample pages@ https://www.precedenceresearch.com/sample/2890

Biotechnology encompasses an array of tools, from traditional breeding techniques to genetic engineering, aimed at modifying organisms to improve product quality, enhance plant and animal characteristics, and tailor microorganisms for specific agricultural applications. This comprehensive approach propels the expansion of the agricultural biotechnology market.

Securing a safe and abundant food supply, cultivated sustainably, stands as a critical global necessity. Agricultural biotechnology, while offering economic and social benefits, requires careful consideration of its impacts. Enhanced crops developed through biotechnology have demonstrated safe usage, yielding advantages such as reduced pesticide dependency. agricultural biotechnology represents only one facet influencing the well-being of farmers and communities, particularly in developing regions. As biotechnology advances, fostering factual and transparent public discourse is essential for defining its societal role.

Establishing robust national biosafety protocols is imperative to nurture domestic biotechnological growth, ensure safe adoption of external innovations, and instill public trust in product safety. Without a conducive regulatory framework, both public and private sectors encounter barriers to investing in biotechnology and bringing its benefits to fruition.

• In January 2024, with support from the Nevada Governor’s Office of Economic Development, TuBiomics emerged as a leader in developing plant and soil health products using sustainable, natural, chemistry-based solutions.

Key Insights

• North America led the global market with the highest market share in 2022.
• By application, the crop production segment registered the maximum market share of 30% in 2022.
• By technology, the genetic engineering segment has held the largest market share of 25% in 2022.
• By type, the hybrid seeds segment captured the biggest revenue share of 30% in 2022.
• By type, the bio-fertilizer segment generated over 26% of revenue share in 2022.

Get full access of this report@ https://www.precedenceresearch.com/sample/2890

Regional Stance

North America held the largest share of the global agricultural biotechnology market. In the United States, agricultural biotechnology serves as a catalyst for enhancing food production globally, mitigating vulnerabilities to pests, viruses, and drought. Recognized as a vital tool in addressing food insecurity and malnutrition, agricultural biotechnology undergoes rigorous risk assessment by national bodies such as the Environmental Protection Agency, the United States Department of Agriculture, and the Food and Drug Administration.

Canada recently reinforced its product-based approach to agricultural biotechnology through published guidelines, bolstering its Novel Food Regulations. Efforts are underway to revise regulations governing animal feed and environmental release, signaling a commitment to fostering innovation in the agricultural sector.

Mexico, renowned for its biodiversity, boasts a diverse landscape of commercial biotechnology activities. With a significant presence in agriculture, environmental applications, healthcare, food, and other sectors, Mexico hosts numerous domestic and international firms driving biotechnological advancements. The country is witnessing exponential growth in biotechnology applications across various domains including healthcare, agriculture, marine resources, and energy production, positioning itself as a burgeoning hub for biotechnological innovation.

• In September 2022, the US launched the National Biotechnology and Biomanufacturing Initiative.

In the European agricultural biotechnology market, key segments include Germany, France, the United Kingdom, Italy, and the Rest of Europe. Within the European Union (EU), stringent regulations mandate that all biotechnology-derived products undergo approval by both EU authorities and Member States (MS) before being utilized in food, feed, or sold as cultivation seed. Approval signifies the products’ safety, ensuring they pose no harm to human or animal health or the environment.

Efforts to promote protein crop cultivation and achieve feed self-sufficiency, the EU remains dependent on substantial imports of genetically engineered (GE) feed to support its livestock sector. This reliance underscores the ongoing necessity for safe, dependable, and cost-effective feed imports to meet agricultural demands.

Advocates for agricultural biotechnology at the EU level include scientists and industry professionals within the agricultural sector, including farmers, seed companies, and representatives of the feed supply chain. These stakeholders play a crucial role in championing the benefits and safety of agricultural biotechnology within the region.

• In February 2022, BRAIN Biotech and Formo announced a strategic partnership of European biotech experts for the production of animal-free milk protein.

In India, the agricultural landscape has undergone a significant transformation since independence, notably with the advent of high-yielding plant varieties resulting from hybridization and selective breeding. This shift, known as the Green Revolution, aimed to enhance crop yields and fortify resistance against various environmental stresses.

China stands out for its substantial investments in biotechnology aimed at bolstering agricultural productivity. Despite significant advancements, including the development of genetically modified (GM) crops, commercialization approval has yet to be granted for many Chinese-developed biotechnological innovations. These regional dynamics underscore the evolving landscape of agricultural biotechnology in the APAC region, with each country navigating unique opportunities and challenges in harnessing biotechnological advancements to address agricultural needs and enhance food security.

The Latin America, Middle East, and Africa (LAMEA) agricultural biotechnology market is divided into distinct segments, including South Africa, North Africa, Saudi Arabia, Brazil, Argentina, and the Rest of LAMEA.

Latin America (LATAM) has emerged as a global leader in the adoption and advancement of agricultural biotechnology, particularly in the cultivation of transgenic crops. Since the mid-1990s, the region has witnessed significant growth in transgenic crop cultivation, with Latin America commanding 45% of the world’s sown area dedicated to such crops.

Among the 19 Latin American countries, ten have embraced genetically modified (GM) crops, with Brazil, Argentina, Paraguay, and Bolivia ranking among the top ten globally in terms of the largest GM crop areas. This robust adoption underscores Latin America’s pivotal role in shaping the trajectory of agricultural biotechnology on a global scale.

Report Highlights

By Application

Notably, the transgenic crops and animals segment led the market in 2023. Transgenesis, a key technology within this segment, facilitates the enhancement of nutrients in animal products, elevating both quantity and quality while tailoring specific nutritional compositions. This technology presents opportunities to transfer or amplify nutritionally beneficial traits, thereby augmenting the overall nutritional profile of animal-derived foods.

Transgenic animals, defined by genomes altered to incorporate genes from other species or through targeted genome editing, exemplify the potential of genetic manipulation to refine animal features for desired traits. Concurrently, transgenic plant production represents a pivotal advancement, enabling the optimization of crop yields and the cultivation of more desirable agricultural products.

Agricultural biotechnology addresses the imperative of sustaining a growing global population while meeting demand for superior-quality agricultural products. This underscores the critical role of biotechnology in advancing food security and agricultural sustainability in the face of mounting challenges.

By Organism Type

In the global agricultural biotechnology market, segmentation by organism type includes plants, animals, and microbes, each further subdivided based on techniques: established genetic modification, conventional techniques, and new breeding techniques. The plants segment emerges as the leader in revenue generation.

Agricultural biotechnology plays a pivotal role in safeguarding crops against detrimental diseases, thereby enhancing crop resilience and bolstering profitability for farmers. Biotech crops offer a range of benefits, from augmenting crop quality to potentially increasing yields. Additionally, the adoption of these crops can streamline farming operations, improving efficiency and safety for farmers.

Biotech crops contribute to enhanced quality traits, such as elevating beta-carotene levels in rice to combat vitamin A deficiencies and refining oil compositions in canola, soybean, and corn. These advancements underscore the transformative potential of agricultural biotechnology in addressing global food security challenges and fostering sustainable agricultural practices.

In the global agricultural biotechnology market, the animal segment is poised for significant growth, projected to achieve the highest compounded annual growth rate (CAGR) throughout the study period. Recent advancements in animal biotechnology have been propelled by breakthroughs in sequencing animal genomes, as well as the analysis of gene expression and metabolic profiling in animal cells.

The emergence of genome editing technologies such as Zinc Finger Nucleases, TALENS, and CRISPR-Cas systems has revolutionized the field, offering unprecedented opportunities to introduce genetic variations in animals. These innovations hold immense promise in enhancing animal health and well-being, optimizing agricultural production, and fortifying animals against diseases. By leveraging these cutting-edge technologies, the animal segment of agricultural biotechnology is poised to drive significant advancements in livestock management and contribute to the sustainable growth of the agricultural sector.

By Technology

The genetic engineering segment led the agricultural biotechnology market in 2023, showcasing its pivotal role in revolutionizing crop improvement, pest resistance, and agricultural sustainability. This dominance underscores the significant strides made in leveraging genetic manipulation techniques to enhance crop traits, increase yields, and mitigate environmental challenges, propelling agricultural innovation and global food security initiatives.

Market Dynamics

Driver

Enhancing Crop Value through Scientific Innovation

Biotechnology serves as a catalyst for elevating the value of plants, animals, and microorganisms by applying scientific techniques to modify and improve their traits. Agricultural biotechnology, a pivotal subset of biotechnology, focuses on enhancing agricultural practices and outcomes. While traditional methods like selection and breeding have long been employed to improve agriculturally significant organisms, genetic engineering technologies represent a groundbreaking frontier in agricultural innovation.

For instance, the development of disease-resistant wheat varieties through cross-breeding demonstrates the historical efficacy of traditional agricultural biotechnology. Moreover, genetic engineering holds immense potential to address health challenges in less developed regions, particularly through the creation of crops fortified with essential vitamins. This innovation not only promises to improve nutritional uptake in impoverished areas but also addresses pressing health concerns such as vitamin A deficiency, which can lead to blindness in children. As such, the integration of genetic engineering in agriculture drives the growth of the agricultural biotechnology market while simultaneously addressing critical global health issues.

Restraint

Consumer and Environmental Concerns

Consumer scepticism and environmental apprehension pose significant hurdles to the growth of the agricultural biotechnology market. Some consumer and environmental groups express reservations about the insufficient understanding of the risks associated with transgenic crops, highlighting potential long-term impacts. Calls for the cessation of genetic engineering research and development further underscore these concerns. The dissemination of conflicting and confusing information often triggers a sense of “dread fear” among individuals, leading to heightened anxiety about the implications of genetic engineering on health and planetary ecology. This fear, fueled by misinformation, can impede progress in agricultural biotechnology. Health, environmental, and social concerns must be systematically addressed to assuage consumer apprehensions and foster trust in the application of biotechnology in agriculture.

Opportunity

Genomic Advancements for Enhanced Crop Production

The evolution of water conservation and purification technologies has laid a foundation for domestic independence in agriculture. Furthermore, recent strides in genomic technologies, including Next generation sequencing (NGS), Ribonucleic acid sequencing (RNA-Seq), Clustered Regularly Interspaced Short Palindromic Repeat-Cas9, Transcription activator-like effector nucleases (TALENS), and Oligonucleotide‐directed mutagenesis (ODM), alongside techniques like doubled haploids, molecular markers, and mapping populations, hold immense promise for bolstering crop production. Coupled with the exponential growth of genome sequence data availability, these advancements have the potential to revolutionize plant breeding practices, presenting a compelling opportunity for the agricultural biotechnology market to increase.

• In March 2023, BASF advanced its innovation pipeline with integrated solutions to accelerate agriculture’s transformation.

Recent Developments

• In February 2022, Eurofins Agro Testing proudly announced the acquisition of Australian Precision Ag Laboratory (APAL).
• In May 2022, Solvay launched a new growth platform focused on renewable materials and biotechnology.
• In July 2023, Olmix Group acquired Brazilian biotech firm Yes Sinergy.
• In January 2023, Bayer launched a new collaboration with Oerth Bio to further advance innovations in crop protection.

Key Players in the Agricultural Biotechnology Market

• ADAMA Ltd
• Bayer AG
• ChemChina
• Corteva
• Evogene Ltd.
• KWS SAAT SE & Co. KGaA
• Limagrain
• Marrone Bio Innovations
• MITSUI & CO., LTD
• Nufarm
• Performance Plants Inc.
• Valent BioSciences LLC

Market Segmentation

• • • • By Application
        • Vaccine Development
        • Transgenic Crops & Animals
        • Antibiotic Development
        • Nutritional Supplements
        • Flower Culturing
        • Biofuels

• • • • By Organism Type
        • Plants
        • Animals
        • Microbes
      • By Type
        • Hybrid Seeds
        • Transgenic Crops
        • Bio-pesticides
        • Bio-fertilizers
      • By Technology
  • Genetic Engineering
    • • • Tissue Culture
        • Embryo Rescue
        • Somatic Hybridization
        • Molecular Diagnostics
        • Vaccine
        • Others
• By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Get full access of this report@ https://www.precedenceresearch.com/checkout/2890

Call: USA: +1 650 460 3308 | IND: +91 87933 22019 | Europe: +44 2080772818

Email: sales@precedenceresearch.com